Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance
Not Applicable
Completed
- Conditions
- Vesicoureteral Reflux
- Interventions
- Procedure: Endoscopic subureteric injection
- Registration Number
- NCT00815334
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatment option for VUR in adults. However, the experience with ESI in adults who have VUR associated with decreased bladder compliance is limited. We evaluated the efficacy of endoscopic subureteral injection treatment for vesicoureteral reflux in adults with decreased bladder compliance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 47
Inclusion Criteria
- Who is aged 18 and greater
- Who underwent endoscopic subureteral injection for vesicoureteral reflux
Exclusion Criteria
- Medical records of whom is not evaluabe
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patients with decreased bladder compliance Endoscopic subureteric injection Patients who have decreased bladder compliance Patients with normal bladder compliance Endoscopic subureteric injection Patients who have normal bladder compliance
- Primary Outcome Measures
Name Time Method Cure rate 3, 12 months
- Secondary Outcome Measures
Name Time Method adverse events 3, 12 months predictive factor for cure 3, 12 months
Trial Locations
- Locations (1)
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of